Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality.

Autor: Allen TS; Division of Preventive Medicine, University of California-San Diego, La Jolla, California, USA., Bui QM; Division of Cardiovascular Medicine, University of California-San Diego, La Jolla, California, USA., Petersen GM; Internal Medicine Residency Program, University of California-San Diego, La Jolla, California, USA., Mantey R; Research Team, CureMetrix, Inc, La Jolla, California, USA., Wang J; Research Team, CureMetrix, Inc, La Jolla, California, USA., Nerlekar N; Baker Heart and Diabetes Institute, Melbourne, Australia.; Victorian Heart Institute & Monash Health Heart, Monash University, Clayton, Australia., Eghtedari M; Department of Radiology, University of California-San Diego, La Jolla, California, USA., Daniels LB; Division of Cardiovascular Medicine, University of California-San Diego, La Jolla, California, USA.

Publikováno v: JACC. Advances [JACC Adv] 2024 Sep 27; Vol. 3 (11), pp. 101283. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

Autor: Rodriguez NJ; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts., Furniss CS; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Yurgelun MB; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts., Ukaegbu C; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Constantinou PE; Sheikh Ahmed Center for Pancreatic Cancer Research, University of Texas, MD Anderson Cancer Center, Houston, Texas., Fortes I; Dana-Farber Cancer Institute, Boston, Massachusetts., Caruso A; Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz AN; Dana-Farber Cancer Institute, Boston, Massachusetts., Stopfer JE; Dana-Farber Cancer Institute, Boston, Massachusetts., Underhill-Blazey M; University of Rochester, School of Nursing, Rochester, New York., Kenner B; Kenner Family Research Fund, New York, New York., Nelson SH; Pancreatic Cancer Action Network Volunteer, Patient Advocate, and Pancreatic Cancer Survivor., Okumura S; Color Genomics, Burlingame, California., Zhou AY; Color Genomics, Burlingame, California., Coffin TB; WIRB-Copernicus Group Institutional Review Board, Puyallup, Washington., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Horiguchi M; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Ocean AJ; Weill Cornell Medical Center, New York, New York., McAllister F; Sheikh Ahmed Center for Pancreatic Cancer Research, University of Texas, MD Anderson Cancer Center, Houston, Texas., Lowy AM; Moores Cancer Center, UC San Diego, San Diego, California., Klein AP; Johns Hopkins University, Sol Goldman Pancreatic Cancer Research Center, Baltimore, Maryland., Madlensky L; Moores Cancer Center, UC San Diego, San Diego, California., Petersen GM; Mayo Clinic Cancer Center, Rochester, Minnesota., Garber JE; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts., Lippman SM; Moores Cancer Center, UC San Diego, San Diego, California., Goggins MG; Johns Hopkins University, Sol Goldman Pancreatic Cancer Research Center, Baltimore, Maryland., Maitra A; Sheikh Ahmed Center for Pancreatic Cancer Research, University of Texas, MD Anderson Cancer Center, Houston, Texas., Syngal S; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: Sapna_Syngal@dfci.harvard.edu.

Publikováno v: Gastroenterology [Gastroenterology] 2024 May; Vol. 166 (5), pp. 872-885.e2. Date of Electronic Publication: 2024 Feb 05.

Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, r -1, t -2,3, c -4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.

Autor: Nguyen S; Department of Public Health, North Dakota State University, Fargo, ND 58105, USA., Carlson H; Fairbanks School of Public Health, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, USA., Yoder A; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Bamlet WR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Oberg AL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Petersen GM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Carmella SG; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Hecht SS; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Jansen RJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Publikováno v: Nutrients [Nutrients] 2024 Feb 28; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 28.

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.

Autor: Hogenson TL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Xie H; Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Division of Medical Oncology, Department of Oncology., Phillips WJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Toruner MD; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Li JJ; Division of Medical Oncology, Department of Oncology., Horn IP; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Kennedy DJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Toruner M; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Koenig-Kappes AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Olson RL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Zhang C; Department of Pharmacology, and., Li H; Department of Pharmacology, and., Doles JD; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA., Bleeker J; Sanford Research, Oncology, Sanford Health, Sioux Falls, South Dakota, USA., Barrett MT; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA., Boyum JH; Department of Radiology., Kipp BR; Department of Laboratory Medicine and Pathology., Mahipal A; Division of Medical Oncology, Department of Oncology., Hubbard JM; Division of Medical Oncology, Department of Oncology., Scheffler Hanson TJ; Division of Medical Oncology, Department of Oncology., Petersen GM; Division of Epidemiology, Department of Quantitative Health Sciences., Dasari S; Division of Computational Biology, Department of Quantitative Health Sciences, and., Oberg AL; Division of Computational Biology, Department of Quantitative Health Sciences, and., Truty MJ; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA., Levy MJ; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Zhu M; Division of Medical Oncology, Department of Oncology., Billadeau DD; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA., Adjei AA; Division of Medical Oncology, Department of Oncology., Dusetti N; Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France., Iovanna JL; Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France., Bekaii-Saab TS; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA., Ma WW; Division of Medical Oncology, Department of Oncology., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: JCI insight [JCI Insight] 2022 Nov 22; Vol. 7 (22). Date of Electronic Publication: 2022 Nov 22.

The age-dependent association of risk factors with pancreatic cancer.

Autor: Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA. Electronic address: chen_yuan@dfci.harvard.edu., Kim J; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA., Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Lee AA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Amundadottir LT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA., Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, USA; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, USA., Li D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., McCullough ML; Department of Population Science, American Cancer Society, Atlanta, USA., Petersen GM; Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, USA., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, USA., Stolzenberg-Solomon RZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA., Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Giovannucci EL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, USA; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Stampfer MJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, USA; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Jul; Vol. 33 (7), pp. 693-701. Date of Electronic Publication: 2022 Apr 06.